other material
confidence high
sentiment negative
materiality 0.75
Axcella Health Inc.: Nasdaq/NYSE listing notice — Axcella Health fails to regain Nasdaq market value compliance; hearing set; bid price deficiency cured
Axcella Health Inc.
- Received Nasdaq notice on Oct 3, 2023 for continued non-compliance with MVPHS ($15M) and MVLS ($50M) listing rules.
- Plans to submit written views to Nasdaq Hearings Panel by Oct 10, 2023; hearing expected Oct 30, 2023 stays delisting.
- Common stock (AXLA) will remain listed and eligible for trading pending final hearing outcome.
- On Oct 4, 2023, Nasdaq confirmed bid price compliance regained (closing bid $1.00+ from Sep 19 to Oct 3); matter closed.